Skip to main content
SpringerLink
Log in
Book cover

New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia pp 205–218Cite as

Molecular biology of APO E alleles in Alzheimer’s and non-Alzheimer’s dementias

  • Conference paper

Part of the book series: Journal of Neural Transmission Supplement ((NEURAL SUPPL,volume 47))

Summary

Current research into the aetiology of the dementias is focused upon genetic factors which give rise to the disease process. Recently the Apolipoprotein E gene (APO E) and in particular the ε4 allele has been shown to be a risk factor for late onset Alzheimer’s disease (AD) where there is an increased frequency of the ε4 allele. The ε4 allele has also been shown to reduce the age at onset of dementia in AD in a dose dependant manner, with the ε2 allele having an opposing effect.

We have genotyped a large series of clinically and neuropathologically confirmed cases of AD and found the expected increase in the Apolipoprotein ε4 allele frequency when compared to a control population. Similarly, in Lewy Body Dementia (LBD) an increased ε4 frequency is also found though a normal ε2 frequency exists, unlike in AD where the ε2 frequency is reduced. No changes in APO E allele frequencies were found in presenile AD, Parkinson’s disease with or without dementia, or in Down’s syndrome. No association was found between any of the APO E alleles and the histopathological indices of AD, cortical senile plaques and neurofibrillary tangles, in any disease category. Neurochemical indicators of AD, loss of choline acetyltransferase activity was also unaffected by APO E genotype.

Whilst their appears to be a strong association between the APO E allele and AD and also in LBD, other related neurodegenerative disorders associated with dementia do not show such a linkage. Changes in the ε2 allele frequency may indicate a genetic difference between AD and LBD. The ε4 allele does not appear to influence the burden of AD type pathology and this is particularly relevant given the relative lack of NFT in LBD indicating that factors other than SP or NFT may govern the onset of dementia.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM (1994) Apolipoprotein E genes in Lewy body and Parkinson’s disease. Lancet 343: 1565

    Article  PubMed  CAS  Google Scholar 

  • Berr C, Hauw J-J, Delaère P, Duyckaerts C, Amouyel P (1994) Apolipoprotein E allele 84 is linked to increased deposition of the amyloid (3-peptide (A-(3) in cases with or without Alzheimer’s disease. Neurosci Lett 178: 221–224

    CAS  Google Scholar 

  • Bètard C, Robitaille Y, Gee M, Tiberghien D, Larrivée D, Roy P, Mortimer JA, Gauvreau D (1994) Apo E allele frequencies in Alzheimer’s disease and vascular dementia. NeuroReport 5: 1893–1896

    Google Scholar 

  • Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B (1995) Fibrillogenesis in Alzheimer’s disease of the amyloid [3 peptides and apolipoprotein E. Biochem J 306: 599–604

    CAS  Google Scholar 

  • Corder E, Basun H, Lannfelt L, Viitanen M, Winblad B (1995) Apolipoprotein E-E4 gene dose. Lancet 346: 967–968

    Article  PubMed  CAS  Google Scholar 

  • Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261: 921–923

    CAS  Google Scholar 

  • Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Rinnuler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, PericakVance MA (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer’s disease. Nature Genet 7: 180–184

    CAS  Google Scholar 

  • Dai XY, Nanko S, Hattori M, Fukuda R, Nagata K, Isse K, Ueki A, Kazamatsuri H (1994) Association of apolipoprotein E4 with sporadic Alzheimer’s disease is more pronounced in early onset type. Neurosci Lett 175: 74–76

    Article  PubMed  CAS  Google Scholar 

  • Evans KC, Berger EP, Cho C-G, Weisgraber KH, Lansbury PT Jr (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 92: 763–767

    CAS  Google Scholar 

  • Feskens EJM, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D (1994) Apolipoprotein E4 allele and cognitive decline in elderly men. Br Med J 309: 1202–1206

    Article  CAS  Google Scholar 

  • Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24: 407–409

    Article  PubMed  CAS  Google Scholar 

  • Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L (1994) The apolipoprotein E allele E4 is over represented in patients with the Lewy body variant of Alzheimer’s disease. Neurology 44: 1950–1951

    CAS  Google Scholar 

  • Ganguli M, Cauley JA, De Kosky ST, Kamboh MI (1995) Dementia among elderly apolipoprotein E type 4/4 homozygotes: a prospective study. Genet Epidemiol 12: 309–311

    CAS  Google Scholar 

  • Goate AM, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance MA, Roses AD, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706

    Article  PubMed  CAS  Google Scholar 

  • Han S-H, Hulette C, Saunders AM, Einstein G, Pericak-Vance M, Strittmatter WJ, Roses AD, Schmechel DE (1994) Apolipoprotein E is present in hippocampal neurones without neurofibrillary tangles in Alzheimer’s disease and in age-matched controls. Exp Neurol 128: 13–26

    CAS  Google Scholar 

  • Hansen LA, Galasko D, Samuel W, Xia Y, Chen X, Saitoh T (1994) Apolipoprotein-E E4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer’s disease. Neurosci Lett 182: 63–65

    Article  PubMed  CAS  Google Scholar 

  • Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer’s disease. Am J Pathol 145: 1472–1484

    CAS  Google Scholar 

  • Helkala E-L, Koivisto K, Hänninen T, Vanhanen M, Kervinen K, Kuusisto J, Mykkänen L, Kesäniemi YA, Laakso M, Riekkinen P Sr (1995) The association of apolipoprotein E polymorphism with memory: a population based study. Neurosci Lett 191: 141–144

    CAS  Google Scholar 

  • Hixon JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545–548

    Google Scholar 

  • Huang DY, Goedert M, Jakes R, Weisgraber KH, Garner CC, Saunders AM, PericakVance MA, Schmechel DE, Roses AD, Strittmatter WJ (1994) Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP 2c: implications for Alzheimer’s disease. Neurosci Lett 182: 55–58

    CAS  Google Scholar 

  • Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995) APO E 4-associated Alzheimer’s disease risk is modified by al-antichymotrypsin polymorphism. Nature Genet 10: 486–488

    CAS  Google Scholar 

  • Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J (1994) Apolipoprotein E polymorphism in Japanese patients with Alzheimer’s disease or vascular dementia. J Neurol Neurosurg Psychiatry 57: 1414–1416

    PubMed  CAS  Google Scholar 

  • Kida E, Choi-Miura N-H, Wisniewski KE (1995) Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer’s disease and Down’s syndrome. Brain Res 685: 211–216

    CAS  Google Scholar 

  • Koller WC, Glatt SL, Hubble JP, Paolo A, Tröster AI, Handler MS, Horvat RT, Martin C, Schmidt K, Karst A, Wijsman EM, Yu C-E, Schellenberg GD (1995) Apolipoprotein E genotypes in Parkinson’s disease with and without dementia. Ann Neurol 37: 242–245

    CAS  Google Scholar 

  • Lannfelt L, Lilius L, Nastase M, Viitanen M, Fratiglioni L, Eggertsen G, Berglund L, Angelin B, Linder J, Winblad B, Basun H (1994) Lack of association between apolipoprotein E allele E4 and sporadic Alzheimer’s disease. Neurosci Lett 169: 175–178

    CAS  Google Scholar 

  • La Du MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform- specific binding of apolipoprotein E to (3-amyloid. J Biol Chem 269: 23403–23406

    Google Scholar 

  • Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala E-L, Partanen K, Ryynänen M, Vainio P, Hartikainen P, Riekkinen PJ Sr (1995) Volumes of hippocampus amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 67: 65–72

    Article  CAS  Google Scholar 

  • Lippa CF, Smith TW, Saunders AM, Crook R, Pulaski-Salo D, Davies P, Hardy J, Roses AD, Dickson D (1995) Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97–103

    CAS  Google Scholar 

  • Locke PA, Conneally PM, Tanzi RE, Gusella JF, Haines JL (1995) Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early-and late-onset cases. Genet Epidemiol 12: 83–92

    Article  PubMed  CAS  Google Scholar 

  • Lucotte G, Visvikis B, Leininger-Miller B, Berriche DS, Réveilleau S, Couderc R, Babron MC, Aguillon D, Siest G (1994) Association of apolipoprotein E allele E4 with late onset sporadic Alzheimer’s disease. Am J Med Genet 54: 286–288

    CAS  Google Scholar 

  • Ma J, Yee A, Brewer B, Jr, Das S, Potter H (1994) Amyloid-associated proteins a-1 antichymotrypsin and apolipoprotein E promote assembly of Alzheimer (3-protein into filaments. Nature 372: 92–94

    CAS  Google Scholar 

  • MacKenzie IRA (1994) Senile plaques do not progressively accumulate with age. Acta Neuropathol 87: 520–525

    Article  PubMed  CAS  Google Scholar 

  • Mahley RW, Rall SC Jr (1989) Type III hyperlipoproteinaemia (dysbetalipoproteinaemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1195–1213

    Google Scholar 

  • Mann DMA, Marcyniuk B, Yates PO, Neary D, Snowden JS (1988) The progression of the pathological changes of Alzheimer’s disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol 14: 177–195

    Article  PubMed  CAS  Google Scholar 

  • Marder K, Maestre G, Cote L, Mejia H, Alfaro B, Halim A, Tang M, Tycko B, Mayeux R (1994) The apolipoprotein E4 allele in Parkinson’s disease with and without dementia. Neurology 44: 1330–1331

    PubMed  CAS  Google Scholar 

  • Martins RN, Clarnette R, Fisher C, Broe GA, Brooks WS, Montgomery P, Gandy SE (1995) Apo E genotypes in Australia: roles in early and late onset Alzheimer’s disease and Down’s syndrome. NeuroReport 6: 1513–1516

    CAS  Google Scholar 

  • Mayeux R, Ottman R, Maestre G, Ngai C, Tang M-X, Ginsberg H, Chun M, Tycko B, Shelanski M (1995) Synergistic effects of traumatic head injury and apolipoprotein-e4 in patients with Alzheimer’s disease. Neurology 45: 555–557

    PubMed  CAS  Google Scholar 

  • McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK (1992) Operational criteria for senile dementia of the Lewy body type (SDLT). Psychol Med 22: 911–922

    Article  PubMed  CAS  Google Scholar 

  • Muramatsu T, Higuchi S, Arai H, Sasaki H, Yamada K, Hayashida M, Trojanowski JO (1994) Apolipoprotein E e4 allele distribution in alcoholic dementia and in Alzheimer’s disease in Japan. Ann Neurol 36: 797–799

    CAS  Google Scholar 

  • Murrel J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with heriditary Alzheimer’s disease. Science 254: 97–99

    Article  Google Scholar 

  • Nalbantoglu J, Gilfix BM, Bertrand P, Robitaille Y, Gauthier S, Rosenblatt DS, Poirer JS (1994) Predictive value of apolipoprotein E genotyping in Alzheimer’s disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 36: 889–895

    CAS  Google Scholar 

  • Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541: 163–166

    CAS  Google Scholar 

  • Nicoll JAR, Roberts GW, Graham DI (1995) Apolipoprotein E E4 allele is associated with deposition of amyloid (3-protein following head injury. Nature Med 1: 135–137

    CAS  Google Scholar 

  • Nitsch RM, Rebeck GW, Deng M, Richardson I, Tennis M, Schenk DB, Vigo-Pelfrey C, Lieberburg I, Wurtman RJ, Hyman BT, Growdon JH (1995) Cerebrospinal fluid levels of amyloid 13-protein in Alzheimer’s disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype. Ann Neurol 37: 512–518

    Article  CAS  Google Scholar 

  • Ohm TG, Kirca M, Bohl J, Scharnagl H, Groß W, März W (1995) Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 66: 583–587

    PubMed  CAS  Google Scholar 

  • Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457–1459

    Article  PubMed  CAS  Google Scholar 

  • Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH (1992) Convergent cholinergic activities in ageing and Alzheimer’s disease. Neurobiol Aging 13: 393–400

    Article  PubMed  CAS  Google Scholar 

  • Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of the Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: 119–139

    Article  PubMed  CAS  Google Scholar 

  • Pickering-Brown SM, Mann DMA, Bourke JP, Roberts DA, Balderson D, Burns A, Byrne J, Owen F (1994) Apolipoprotein E4 and Alzheimer’s disease pathology in Lewy body disease and in other (3-amyloid-forming diseases. Lancet 343: 1155

    Article  PubMed  CAS  Google Scholar 

  • Poirer J, Davignon J, Bouthillier D, Kogan S, Bertrand D, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet 342: 697–699

    Google Scholar 

  • Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron 11: 575–580

    CAS  Google Scholar 

  • Roses AD (1994a) Apolipoprotein E affects the rate of Alzheimer’s disease expression: (3-amyloid burden is a secondary consequence dependant on Apo E genotype and duration of disease. J Neuropathol Exp Neurol 53: 429–437

    CAS  Google Scholar 

  • Roses AD, (1994b) Apolipoprotein E is a relevant susceptibility gene that affects rate of expression of Alzheimer’s disease. Neurobiol Aging 15: S165–S167

    Article  Google Scholar 

  • Roses AD (1995) Apolipoprotein E genotyping in the differential diagnoses not prediction, of Alzheimer’s disease. Ann Neurol 38: 6–14

    PubMed  CAS  Google Scholar 

  • Royston MC, Mann D, Pickering-Brown S, Owen F, Perry R, Raghavan R, Khin-Nu C, Tyrer S, Day K, Crook R, Hardy J, Roberts GW (1994) Apolipoprotein E E2 allele promotes longevity and protects patients with Down’s syndrome from dementia. NeuroReport 5: 2583–2585

    CAS  Google Scholar 

  • Sanan DA, Weisgraber KH, Russel SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994) Apolipoprotein E associates with (3-amyloid peptide of Alzheimer’s disease to form novel monofibris. Isoform Apo E4 associates more efficiently than Apo E3. J Clin Invest 94: 860–869

    CAS  Google Scholar 

  • Saunders AM, Strittmatter WJ, Schmechel D, St George Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43: 1467–1472

    CAS  Google Scholar 

  • Schmechel DE, Saunders AM, Strittmatter WJ, Crain B, Hulette CM, Joo SH, PericakVance MA, Goldgaber D, Roses AD (1993) Increased amyloid 13-peptide deposition as a consequence of apolipoprotein E genotype in late onset Alzheimer’s disease. Proc Natl Acad Sci USA 90: 9649–9653

    Article  CAS  Google Scholar 

  • Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early onset familial Alzheimer’s disease. Nature 375: 754–760

    Article  PubMed  CAS  Google Scholar 

  • Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljärvi L, Talasniemi S, Ryynänen M, Riekkinen P Sr (1995) A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein E4 allele. Neurosci Lett 187: 79–82

    Article  PubMed  CAS  Google Scholar 

  • Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco L, Piacentini S, Amaducci L (1994) Apo E allele frequencies in Italian sporadic and familial Alzheimer’s disease. Neurosci Lett 177: 100–102

    CAS  Google Scholar 

  • St Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A (1994) Apolipoprotein E E4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 176: 45–46

    CAS  Google Scholar 

  • Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance AM, Enghild J, Salvesen GS, Roses AD (1993a) Apolipoprotein E: high avidity binding to 13-amyloid and increased frequency of type E4 allele in late-onset familial Alzheimer’s disease. Proc Natl Acad Sci USA 90: 1977–1981

    Article  CAS  Google Scholar 

  • Strittmatter WJ, Weisgraber KM, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance AM, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993b) Binding of human apolipoprotein E to synthetic amyloid 13 peptide: isoform specific effects and implications for late onset Alzheimer’s disease. Proc Natl Acad Sci USA 90: 8098–8102

    CAS  Google Scholar 

  • Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KM, Dong L-M, Jakes R, Huang DY, Pericak-Vance AM, Schmechel D, Roses AD (1994a) Isoform specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer’s disease. Proc Natl Acad Sci USA 91: 11183–11186

    CAS  Google Scholar 

  • Strittmatter W, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Han SH, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses A (1994) Hypothesis: microtubule instability and paired helical filament formation in Alzheimer’s disease brain are related to apolipoprotein E genotype. Exp Neurol 125: 163–171

    Article  CAS  Google Scholar 

  • van Broeckhoven C, Backhovens H, Cruts M, Martin JJ, Crook R, Houlden H, Hardy J (1994) APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer’s disease. Neurosci Lett 169: 179–180

    Article  PubMed  Google Scholar 

  • van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease. Nature Genet 7: 74–78

    Article  PubMed  Google Scholar 

  • van Duijn CM, de Knijff P, Wehnert A, De Voecht J, Bronzova JB, Havekes LM, Hofman A, Van Broeckhoven C (1995) The apolipoprotein E E2 allele is associated with an increased risk of early-onset Alzheimer’s disease and a reduced survival. Ann Neurol 37: 605–610

    Google Scholar 

  • Wenham PR, Price WH, Blundell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158–1159

    CAS  Google Scholar 

  • Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am J Pathol 145: 1030–1035

    CAS  Google Scholar 

  • Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, Hamaguchi H (1994) Dose-dependant association of Apolipoprotein E allele E4 with late onset sporadic Alzheimer’s disease. Ann Neurol 36: 656–659

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Neurochemical Pathology Unit and Department of Neuropathology, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne, Tyne and Wear, NE4 6BE, UK

    Dr. C. M. Morris, H. M. Massey, R. Benjamin, A. Leake, C. Broadbent, M. Griffiths, H. Lamb, A. Brown, P. G. Ince, S. Tyrer, P. Thompson, I. G. McKeith, J. A. Edwardson, R. H. Perry & E. K. Perry

Authors
  1. Dr. C. M. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. Massey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Benjamin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Leake
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Broadbent
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Griffiths
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Lamb
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. G. Ince
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S. Tyrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P. Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. I. G. McKeith
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J. A. Edwardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. R. H. Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. E. K. Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. L. Boltzmann Institute of Clinical Neurobiology, Lainz-Hospital, Vienna, Austria

    Kurt A. Jellinger

  2. EBEWE-Research Initiative, Graz, Austria

    Manfred Windisch

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag

About this paper

Cite this paper

Morris, C.M. et al. (1996). Molecular biology of APO E alleles in Alzheimer’s and non-Alzheimer’s dementias. In: Jellinger, K.A., Windisch, M. (eds) New Trends in the Diagnosis and Therapy of Non-Alzheimer’s Dementia. Journal of Neural Transmission Supplement, vol 47. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6892-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6892-9_14

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82823-6

  • Online ISBN: 978-3-7091-6892-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation